Works by Tan, David S. P.

Results: 22

Microarray-Based Class Discovery for Molecular Classification of Breast Cancer: Analysis of Interobserver Agreement.
Published in:
JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 8, p. 662, doi. 10.1093/jnci/djr071
By:
- Mackay, Alan;
- Weigelt, Britta;
- Grigoriadis, Anita;
- Kreike, Bas;
- Natrajan, Rachael;
- A'Hern, Roger;
- Tan, David S. P.;
- Dowsett, Mitch;
- Ashworth, Alan;
- Reis-Filho, Jorge S.
Publication type:
Article
The Role of Immunotherapy in the Treatment of Advanced Cervical Cancer: Current Status and Future Perspectives.
Published in:
Journal of Clinical Medicine, 2021, v. 10, n. 19, p. 4523, doi. 10.3390/jcm10194523
By:
- Walsh, Robert J.;
- Tan, David S. P.
Publication type:
Article
Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials.
Published in:
British Journal of Cancer, 2023, v. 128, n. 8, p. 1514, doi. 10.1038/s41416-023-02193-2
By:
- Loh, Jerold;
- Wu, Jiaxuan;
- Chieng, Jenny;
- Chan, Aurora;
- Yong, Wei-Peng;
- Sundar, Raghav;
- Lee, Soo-Chin;
- Wong, Andrea;
- Lim, Joline S. J.;
- Tan, David S. P.;
- Soo, Ross;
- Goh, Boon-Cher;
- Tai, Bee-Choo;
- Chee, Cheng E.
Publication type:
Article
Biomarkers for Homologous Recombination Deficiency in Cancer.
Published in:
2018
By:
- Hoppe, Michal M.;
- Sundar, Raghav;
- Tan, David S. P.;
- Jeyasekharan, Anand D.
Publication type:
journal article
Molecular profiling of metastatic breast cancer and target-based therapeutic matching in an Asian tertiary phase I oncology unit.
Published in:
Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1342346
By:
- Walsh, Robert John;
- Ong, Rebecca;
- Seng Wee Cheo;
- Low, Peter Q. J.;
- Jayagopal, Aishwarya;
- Lee, Matilda;
- Ngoi, Natalie;
- Ow, Samuel G.;
- Wong, Andrea L. A.;
- Siew Eng Lim;
- Yi Wan Lim;
- Heong, Valerie;
- Sundar, Raghav;
- Soo, Ross A.;
- Cheng Ean Chee;
- Wei Peng Yong;
- Goh, Boon Cher;
- Soo Chin Lee;
- Tan, David S. P.;
- Lim, Joline S. J.
Publication type:
Article
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.
Published in:
Nature Reviews Cancer, 2013, v. 13, n. 4, p. 273, doi. 10.1038/nrc3432
By:
- Kipps, Emma;
- Tan, David S. P.;
- Kaye, Stan B.
Publication type:
Article
Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor.
Published in:
Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-30686-1
By:
- Subhash, Vinod Vijay;
- Yeo, Mei Shi;
- Wang, Lingzhi;
- Tan, Shi Hui;
- Wong, Foong Ying;
- Thuya, Win Lwin;
- Tan, Woei Loon;
- Peethala, Praveen C.;
- Soe, Mu Yar;
- Tan, David S. P.;
- Padmanabhan, Nisha;
- Baloglu, Erkan;
- Shacham, Sharon;
- Tan, Patrick;
- Koeffler, H. Phillip;
- Yong, Wei Peng
Publication type:
Article
Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) Study.
Published in:
International Journal of Cancer, 2018, v. 142, n. 9, p. 1890, doi. 10.1002/ijc.31091
By:
- Heong, Valerie;
- Syn, Nicholas L.;
- Lee, Xiao Wen;
- Sapari, Nur Sabrina;
- Koh, Xue Qing;
- Adam Isa, Zul Fazreen;
- Sy Lim, Joey;
- Lim, Diana;
- Pang, Brendan;
- Thian, Yee Liang;
- Ng, Lai Kuan;
- Wong, Andrea L.;
- Soo, Ross Andrew;
- Yong, Wei Peng;
- Chee, Cheng Ean;
- Lee, Soo‐Chin;
- Goh, Boon‐Cher;
- Soong, Richie;
- Tan, David S. P.
Publication type:
Article
Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?
Published in:
Genes, Chromosomes & Cancer, 2009, v. 48, n. 4, p. 351, doi. 10.1002/gcc.20646
By:
- Natrajan, Rachael;
- Lambros, Maryou B. K.;
- Geyer, Felipe C.;
- Marchio, Caterina;
- Tan, David S. P.;
- Vatcheva, Radost;
- Shiu, Kai-Keen;
- Hungermann, Daniela;
- Rodriguez-Pinilla, Socorro Maria;
- Palacios, Jose;
- Ashworth, Alan;
- Buerger, Horst;
- Reis-Filho, Jorge S.
Publication type:
Article
Editorial: Harnessing DNA Damage Response in Gynecologic Malignancies.
Published in:
2022
By:
- Tse, Ka Yu;
- Liu, Jihong;
- Lee, Sung-Jong;
- Tan, David S. P.
Publication type:
Editorial
Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experience.
Published in:
Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e69
By:
- Wijaya, Silvana Talisa;
- Ngoi, Natalie Y. L.;
- Loh, Jerold W. Z.;
- Tuan Zea Tan;
- Lim, Diana;
- Khan, Irfan Sagir;
- Yee Liang Thian;
- Lai, Alexa;
- Ang, Bertrand W. L.;
- Tong, Pearl;
- Ng, Joseph;
- Low, Jeffrey J. H.;
- Ilancheran, Arunachalam;
- Siew Eng Lim;
- Yi Wan Lim;
- Tan, David S. P.
Publication type:
Article
Closing the gap for cervical cancer research in Vietnam: current perspectives and future opportunities: a report from the 5th Gynecologic Cancer InterGroup (GCIG) Cervical Cancer Research Network (CCRN) Education Symposium.
Published in:
Journal of Gynecologic Oncology, 2023, v. 34, n. 5, p. 1, doi. 10.3802/jgo.2023.34.e88
By:
- Phan, Ngoc T. H.;
- Tran, Quy T.;
- Nguyen, Nhan P. T.;
- Nguyen, Hang T.;
- Tran, Linh D. N.;
- Pham, Viet C.;
- Bennett, Katherine;
- Chávez-Blanco, Adriana;
- Plante, Marie;
- Dong Hoon Suh;
- Nout, Remi;
- Tan, David S. P.
Publication type:
Article
A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01).
Published in:
Journal of Gynecologic Oncology, 2021, v. 32, n. 2, p. 1, doi. 10.3802/jgo.2021.32.e31
By:
- Yong Jae Lee;
- Myong Cheol Lim;
- Byoung-Gie Kim;
- Chel Hun Choi;
- Sang-Yoon Park;
- Tan, David S. P.;
- Yunjung Go;
- Jung-Yun Lee
Publication type:
Article
Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore.
Published in:
Journal of Gynecologic Oncology, 2021, v. 32, n. 2, p. 1, doi. 10.3802/jgo.2021.32.e27
By:
- Tan, David S. P.;
- Chan, Jack Junjie;
- Hettle, Robert;
- Ghosh, Wrik;
- Viswambaram, Amrita;
- Yu, Cindy Chen
Publication type:
Article
The 4th European Society for Medical Oncology Asia Congress: bridging ultimate cancer care with real-world practice for the Asian practitioner in gynecological cancers.
Published in:
Journal of Gynecologic Oncology, 2019, v. 30, n. 2, p. 1, doi. 10.3802/jgo.2019.30.e48
By:
- Ngoi, Natalie Y. L.;
- Tan, David S. P.
Publication type:
Article
Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
Published in:
Journal of Gynecologic Oncology, 2018, v. 29, n. 6, p. 1, doi. 10.3802/jgo.2018.29.e96
By:
- Lee, Matilda X.;
- Tan, David S. P.
Publication type:
Article
Understanding Resistance Mechanisms and Expanding the Therapeutic Utility of PARP Inhibitors.
Published in:
Cancers, 2017, v. 9, n. 8, p. 109, doi. 10.3390/cancers9080109
By:
- Lim, Joline S. J.;
- Tan, David S. P.
Publication type:
Article
Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinoma.
Published in:
Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-75536-1
By:
- Yabuno, Akira;
- Matsushita, Hirokazu;
- Hamano, Tetsutaro;
- Tan, Tuan Zea;
- Shintani, Daisuke;
- Fujieda, Nao;
- Tan, David S. P.;
- Huang, Ruby Yun-Ju;
- Fujiwara, Keiichi;
- Kakimi, Kazuhiro;
- Hasegawa, Kosei
Publication type:
Article
Targeting the immune microenvironment for ovarian cancer therapy.
Published in:
Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1328651
By:
- Blanc-Durand, Felix;
- Lai Clemence Wei Xian;
- Tan, David S. P.
Publication type:
Article
Lipidomic Analysis of Archival Pathology Specimens Identifies Altered Lipid Signatures in Ovarian Clear Cell Carcinoma.
Published in:
Metabolites (2218-1989), 2021, v. 11, n. 9, p. 597, doi. 10.3390/metabo11090597
By:
- Mir, Sartaj Ahmad;
- Wong, Soon Boon Justin;
- Narasimhan, Kothandaraman;
- Esther, Chua W. L.;
- Ji, Shanshan;
- Burla, Bo;
- Wenk, Markus R.;
- Tan, David S. P.;
- Bendt, Anne K.
Publication type:
Article
A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies.
Published in:
Targeted Oncology, 2023, v. 18, n. 3, p. 391, doi. 10.1007/s11523-023-00962-w
By:
- Chee, Cheng E.;
- Ooi, Melissa;
- Lee, Soo-Chin;
- Sundar, Raghav;
- Heong, Valerie;
- Yong, Wei-Peng;
- Ng, Chin Hin;
- Wong, Andrea;
- Lim, Joline S. J.;
- Tan, David S. P.;
- Soo, Ross;
- Tan, Joshua T. C.;
- Yang, Song;
- Thura, Min;
- Al-Aidaroos, Abdul Qader;
- Chng, Wee Joo;
- Zeng, Qi;
- Goh, Boon-Cher
Publication type:
Article
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors.
Published in:
Targeted Oncology, 2022, v. 17, n. 2, p. 141, doi. 10.1007/s11523-022-00867-0
By:
- Lee, Matilda Xinwei;
- Wong, Andrea L. A.;
- Ow, Samuel;
- Sundar, Raghav;
- Tan, David S. P.;
- Soo, Ross A.;
- Chee, Cheng Ean;
- Lim, Joline S. J.;
- Yong, Wei Peng;
- Lim, Siew Eng;
- Goh, Boon Cher;
- Wang, Lingzhi;
- Lee, Soo Chin
Publication type:
Article